text:
Clinical Advisory Board
Geoffrey S. Baird, MD, Ph.D. - Chair
Dr. Baird is the Chair of the Avalon Clinical Advisory Board. He is board-certified in Anatomic and Clinical Pathology as well as Clinical Chemistry. Dr. Baird serves as both Interim Chair and Associate Professor of Laboratory Medicine as well as an Adjunct Associate Professor of Pathology at the University of Washington in Seattle, WA. He is the Laboratory Medical Director at Northwest Hospital and Airlift Northwest, and the Director of Clinical Chemistry at Harborview Medical Center. He was formerly the Associate Program Director of the UW Clinical Pathology Residency Program and Director of the UW Clinical Chemistry Fellowship Program.
Dr. Baird serves on numerous local and national committees, including the CMS/PAMA Clinical Diagnostic Laboratory Test Panel and ASCP's Choosing Wisely Campaign Committee where he has been instrumental in developing the ASCP's Choosing Wisely recommendations. He is the recipient of the AACC's Grannis Award for Excellence in Research and Scientific Publication and the International Federation of Clinical Chemistry's Young Investigator award.
Dr. Baird is a member of the Academy of Clinical Laboratory Physicians and Scientists. His clinical interests include rational laboratory test utilization, chemistry and toxicology, molecular diagnostics and proteomics.
Dr. Baird is a graduate of Stanford University with a BS in Chemistry. He received his MD and PhD at the University of California, San Diego, and did his residency in Anatomic and Clinical Pathology at the University of Washington in Seattle.
Timothy R. Hamill, MD
Dr. Timothy Hamill is the Prior Director of Clinical Laboratories at UCSF Medical Center's China Basin and Parnassus campuses. In addition, he is Professor Emeritus and Ex-Vice Chair of the UCSF Department of Laboratory Medicine.
Dr. Hamill has held numerous memberships in UCSF Medical Center committees in his tenure, including the position of chair of the UCSF Medical Center Point of Care Testing Committee. He is also past chair of the California Department of Health Services Clinical Laboratory Technology Advisory Committee (CLTAC). He is currently President and member of the Board for the California Society of Pathologists, and a fellow of the American Society of Clinical Pathologists and College of American Pathologists.
In his career, Dr. Hamill has taken a lead in promoting laboratory science as a career and clinical laboratory scientist training as the Co-Chair of the Hospital Laboratory Workforce Initiative of the California Hospital Association. In addition, he has also been involved in developing better point-of-care testing practices through the College of American Pathologists as the Vice-Chair of the Point of Care Testing Resource Committee.
Dr. Hamill completed his medical degree from UC Davis' School of Medicine. He was the chief resident in the departments of Laboratory Medicine at UCSF and San Francisco General Hospital. In addition, he completed a fellowship in Hematopathology at the Veterans Administration Medical Center in Martinez, CA. He is board-certified in clinical pathology and also hematopathology.
Victoria M. Pratt, Ph.D.
Dr. Pratt is a Medical and Clinical Molecular Geneticist board-certified by the American College of Medical Genetics. She is the Director of the Pharmacogenomics Laboratory at Indiana University School of Medicine. Prior to joining Indiana University, she was Chief Director, Molecular Genetics, for Quest Diagnostics Nichols Institute.
In addition to her work, Dr. Pratt is currently serving on the Centers for Medicare and Medicaid Services Clinical Diagnostic Laboratory Tests Advisory Panel. Dr. Pratt continues to serve on the CDC's GeT-RM program for reference materials for Molecular Genetics. She is currently serving on the Institute of Medicine/National Academy of Medicine's Roundtable on Translating Genomic-Based Research for Health and Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies. She also served on the U.S. Secretary of Health and Human Services Advisory Committee on Genetics, Health and Society for the Oversight of Genetic Testing and the Advisory Committee on Hereditary Disorders in Newborns and Children. She also participated in the preparation of the Morbidity and Mortality Weekly Report for Best Practices in Molecular Genetic Testing for the Centers for Disease Control and Prevention (CDC).
Dr. Pratt is Past Chair of the Clinical Practice Committee and is currently a member of the Professional Relations committee, and is the chair of the Program committee for the Association of Molecular Pathology. She is a former advisor of EurogenTest for genetic test validation. Dr. Pratt serves on the American Medical Association's (AMA's) Molecular Pathology Current Procedural Terminology (CPT) Advisory committee.
Dr. Pratt has authored over 50 peer-reviewed manuscripts and book chapters. She is also an Associate Editor for the Journal of Molecular Pathology.
Dr. Pratt graduated with a Ph.D. in Medical and Molecular Genetics from Indiana University School of Medicine, Indianapolis, IN in 1994. Her fellowship training was in Ph.D. Medical and Clinical Molecular Genetics at Henry Ford Hospital, Detroit MI.
Brian P. Rubin, MD, Ph.D.
Dr. Rubin is Professor and Vice Chair of Pathology, Director, Soft Tissue Pathology, Director, Bone & Soft Tissue Pathology Fellowship Program, Staff, Department of Cancer Biology and Practicing Pathologist with sub-specialty expertise in bone and soft tissue tumors, Cleveland Clinic
Dr. Rubin is Staff, Department of Cancer Biology, Lerner Research Institute and Cleveland Clinic
Clinical Interests: Bone and Soft Tissue Tumor Diagnosis and Classification, Cancer Genetics, Digital Pathology, Molecular Pathology
Brian R. Smith, MD
Dr. Smith is Chair of the Department of Laboratory Medicine at the Yale School of Medicine and Professor of Laboratory Medicine, Biomedical Engineering, Internal Medicine and Pediatrics at Yale University. He is also the Chief of Laboratory Medicine at Yale New Haven Hospital.
Dr. Smith received his undergraduate degree from Princeton University, his medical degree from the Harvard Medical School, and his residency/fellowship training at The Brigham & Women's Hospital, Boston Children's Hospital, and Dana Farber Cancer Center. He is board certified in Pathology / Hematopathology and in Internal Medicine / Hematology-Oncology. He practices in all of his subspecialty areas. In addition to his clinical work, Dr. Smith has an investigative interest in the inflammation-coagulation interface, especially in relation to biomaterials, as well as in cellular immunotherapeutics, with over 175 publications. His educational activities include direction of an NIH-funded research training program in Immunohematology and Transfusion Medicine. He also lectures in the areas of biomedical ethics, "therapeutic pathology", and in the education of the physician-scientist. Nationally, he has been member and chair for various NIH and American Heart Association research study sections, chair of the Association of Pathology Chairs Research Committee, and a member of the CDC Clinical Laboratory Integration into Healthcare Collaborative. He is the recipient of a number of Awards including Stohlman Scholar of the Leukemia & Lymphoma Society, National Blood Foundation Scholar, the Evans Award from the Academy of Clinical Laboratory Physicians and Scientists, and has served as a visiting professor at a number of universities.


text:
Hair Hydration
Hydration is an essential part of healthy, strong, beautiful hair.
Harklinikken´s unique Hydration products are made to restore the strength and shine in thinning hair. All the products in Harklinikken´s Hydration line are only made with ingredients you can trust and contains no color, perfume, silicone, petrochemicals, parabens or SLS/SLES.

subset: commoncrawl


text:
Water is a Foundation's Biggest Nemesis
Water is a foundation's biggest nemesis. Water causes the soil beneath a home to move, resulting in settling, cracks, bowed walls, and other foundation concerns. A home's foundation comes in direct contact with the ground. The foundation's primary purpose is to join the structure of the building to soil or rock beneath.
However, the partnership between a foundation and the ground beneath can be volatile. The movement of the soil can seriously damage a home's foundation.
While a foundation may seem like a solid, immovable force, the ground around it is constantly moving and changing.
Wet periods, which can be caused by rainfall, snowmelt, or a high water table, cause the ground to expand.
During a drought or other dry period, the ground contracts.
In the United States, the proportion of clay, silt, and sand contained in soil affects the amount of water it can hold.
Clay soil is considered an "expansive soil" and contracts and expands depending on moisture content. Other soils, such as loam or sand don't absorb as much water as clay and offer better drainage.
The cycle of expansion and contraction puts pressure on a foundation, causing it to shift and move. Enough movement can crack walls, buckle floors and jar door or window frames.
If there isn't proper draining around a home, some areas of soil may swell more than others. At the same time, other areas may dry out quickly. The result is a foundation more supported in one section than another. The unbalance leads to foundation troubles.
With the soil eroded, foundation walls or flooring can settle and crack.
Vegetation, such as trees, shrubs or other plants, around a foundation can affect moisture levels.
Plants and trees can desiccate (remove moisture) from the soil around foundations during dry weather. Dry soil compacts and draws away from a foundation, allowing walls to move and shift.
Preventing foundation damage requires vigilance and awareness. Do a visual inspection of your house. Look for standing water, clogged gutters or ground sloped toward your foundation.
Major foundation issues will require a professional to fix or mitigate. However, small changes, such as cleaning gutters or re-directing downspouts can make an impact.
- Featured Job: Atlas Systems Stabilizes and Lifts Settling and Cracked Foundation
- Featured Job: Atlas Systems Uses ECP Resistance Piers for Chimney Support
- A Look at Our Pro Series Combination Pumps
- Why You Should Join The ECP Network Part 2
- Why Should You Join The ECP Network?
- Construction Today Features ECP


text:
Jones Day continued its push to escape portions of a lawsuit accusing it of rampant sex discrimination against female attorneys while the attorneys simultaneously sought to sure up their claims.
A third amended complaint filed Aug. 16 by a proposed class of women was proper and expected, because it was actually the one amendment federal procedural rules allow as of right, the attorneys say in a Sept. 3 filing opposing Jones Day's motion to strike that pleading. The second amended complaint they filed Aug. 13 was required by the court in response to the denial of a former named plaintiff's request to proceed in the case using a pseudonym rather than her real name, they say.
No federal court in the District of Columbia, where the case is pending, has ever held that plaintiffs may file an amended complaint as of right after having previously amended their lawsuit at a judge's instruction. But the U.S. Court of Appeals for the Ninth Circuit has allowed the move, the women say.
If Judge Randolph D. Moss denies that approach, he should grant them leave to amend and accept the third amended complaint as proper on that basis, the women say.
Jones Day, in a Sept. 3 filing supporting its separate motion for partial judgment on the pleadings, objects to that approach. The third amended complaint wasn't filed as of right and wasn't proper without the court's approval, the firm says. It declined to address the latest complaint's additional allegations in its reply to a separate motion but asked for the chance to file further briefing on the merits should the third amended complaint be accepted by the court.
Regardless of which complaint is deemed "operative," the case should go forward with fewer claims, the firm says. The women's attempt to bolster their class allegations still lacks details regarding how the firm's employment policies and culture result in systemic bias based on sex, Jones Day says.
They point to three aspects of Jones Day's alleged "black box" compensation system as "facially neutral" job practices supporting their disparate impact claims, but none fits the bill, the firm says. They also still fail to assert a single act of discrimination by Managing Partner Stephen J. Brogan, who allegedly presides over the bias, Jones Day says.
Sanford Heisler Sharp represents the women. Jones Day represents itself.
The case is Tolton v. Jones Day, D.D.C., No. 1:19-cv-00945, motion papers filed 9/3/19.
To contact the reporter on this story:
To contact the editors responsible for this story:


text:
|'Magic in the Air' 9x12 pastel ©Karen Margulis
purchase here $150
|my notan created with sharpie black markers
The Magnum Sharpie worked great for my little notan thumbnail. I used a 4x6 index card for the notan. I used a regular sharpie to draw in a few of the thinner tree shapes. I liked doing the notan. It made it easy to see the shapes. I could see if I had interesting shapes and arrangement of dark and light. It was also quick to do....no thumbnail excuses!
But then I put in my "what if" hat. What if I used the Sharpie and created the notan right on my pastel paper? I have not had the pleasure of watching Tony Allain paint but friends have told me he will sometimes use sharpie markers to start a painting. What a great idea! I could use the sharpie to mass in my big dark shapes. I was curious to see how it would work as an underpainting for a landscape.
I selected a piece of gray Canson Mi-Teinte paper for my painting. The sharpie marker worked well on the paper and I was able to block in the dark shapes of the trees and the dark shape leading through the meadow. I also used the thin sharpie to draw some of the tree branches. I now had a nice value map to follow.
It was simple to reinforce the dark areas with pastels that were close in value to the black shapes. I could easily see if a pastel was too light when placed on top of the black marker shapes. It helped me keep my dark shapes strong which was important in order to create the illusion of the glow of the setting sun.
Sometimes it seems like we have too many choices when starting a painting. Using a notan and then actually recreating the same notan with marker as an underpainting is an unexpected but simple way to give a painting a strong start!
Can you help? I am putting together a new program this year and need your questions about underpaintings. If you have any questions about anything to do with underpaintings send them to me at firstname.lastname@example.com. I appreciate your input!